Clinical Trial Update: An Exploratory Clinical Study of CD19 CAR NK Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases [Phase 1]

View source ↗

Summary

Phase 1 exploratory study evaluating CD19 CAR NK cell injections for relapsed/refractory autoimmune diseases; recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases

Drugs mentioned

• CD19 CAR NK cells (CD19 CAR NK cell therapy)

Snippet

Sponsor: Changhai Hospital | Conditions: Autoimmune Diseases | Phase 1 | Status: RECRUITING